Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
AQX-1125 200 mg
DRUG
2 trials
Sponsors
Aquinox Pharmaceuticals (Canada) Inc.
Conditions
Bladder Pain Syndrome
Chronic Interstitial Cystitis
Chronic Pelvic Pain Syndrome
Chronic Prostatitis
Interstitial Cystitis
Painful Bladder Syndrome
Phase 2
Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Terminated
NCT03500159
Aquinox Pharmaceuticals (Canada) Inc.
Chronic Pelvic Pain Syndrome, Chronic Prostatitis
Start: 2018-04-18
End: 2018-07-17
Updated: 2019-01-09
Phase 3
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
NCT02858453
Aquinox Pharmaceuticals (Canada) Inc.
Bladder Pain Syndrome, Chronic Interstitial Cystitis, Interstitial Cystitis +1
Start: 2016-07-31
End: 2020-02-29
Updated: 2018-03-15